ArticleBritish journal of cancer2016

Optimising the combination dosing strategy of abemaciclib and vemurafenib in BRAF-mutated melanoma xenograft tumours.

Sonya C Tate et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.